137 results
Page 2 of 7
8-K
EX-99.1
rbuyg6de8zhw4q23vc
12 Aug 22
Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
7:08am
8-K
EX-99.1
sxzbbm0k1 bepquq2
21 Jun 22
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
7:00am
8-K
m4uzrat5mjsix ri
8 Jun 22
Submission of Matters to a Vote of Security Holders
6:01am
8-K
EX-99.1
g5ap5wz8ywx
12 May 22
Therapeutics Announces First Quarter 2022 Financial Results and Provides
6:20am
424B5
6nmkob
25 Apr 22
Prospectus supplement for primary offering
4:19pm
8-K
EX-99.1
gqtg3z5h03timrqfq8n
9 Mar 22
Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial
6:05am
8-K
EX-99.1
lyix7r957gn 8iofi085
16 Dec 21
Chemomab Therapeutics Announces Expected Appointment of Dale R. Pfost as Chairman of the Board
4:05pm
8-K
EX-99.1
eqd9 kvyz0
3 Dec 21
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
8:05am
8-K
EX-99.1
spzpu1eo5lfyr4p8x7u
12 Nov 21
Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
7:44am
8-K
EX-99.1
dl85q3 4tu5guqcqa
10 Nov 21
Regulation FD Disclosure
5:06pm
8-K
EX-99.1
c5oubf6i8ti 5qm
8 Nov 21
Departure of Directors or Certain Officers
7:35am
8-K
EX-99.1
6j2 nqeeab
3 Nov 21
Regulation FD Disclosure
4:06pm
8-K
EX-99.1
aauteo3lvclz32v3
25 Oct 21
Regulation FD Disclosure
4:02pm
8-K
EX-99.2
52bkz8rtg2r3o3x892x1
2 Sep 21
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief
7:11am
8-K
EX-99.1
gdnkhyxxhwmx6yly
2 Sep 21
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief
7:11am